Immix Biopharma to Present at the Stifel 2024 Cell Therapy Forum

The IMMX Team will be available for institutional investor meetings during the Contacts Mike Moyer LifeSci Advisors mmoyer@lifesciadvisors.com LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced that it will present and host institutional investor meetings at the Stifel 2024 Cell Therapy Forum. Immix Biopharma, Inc. (ImmixBio) (Nasdaq ...